InvestorsHub Logo
Followers 6
Posts 2155
Boards Moderated 0
Alias Born 11/26/2014

Re: tilator post# 31495

Monday, 12/04/2017 2:34:55 PM

Monday, December 04, 2017 2:34:55 PM

Post# of 38634
Tilator- Percentage on PAR deal is likely not going up. With all doses on market though, IPCI should get $4-5M in revenue on Focalin XR for FY 2018. What is so sad is analysts were calling for ridiculously high numbers on Seroquel XR. I said they were way too high. I said $3M per quarter. Now it looks like my estimate was way too high as well...